Irina Vergalasova - Search Results

Year	Number of Results
2011	1
2012	1
2013	1
2015	1
2017	2
2019	3
2020	10
2021	12
2022	7
2023	1
2024	1

1

Disparities in brachytherapy utilization in cervical cancer in the United States: A comprehensive literature review.

Kumar R, Sherwani Z, Lopez M, Vergalasova I, Zhang X, Eckroate B, Hollingsworth J, Girda E, Hathout L. Kumar R, et al. Among authors: vergalasova i. Gynecol Oncol. 2023 Dec;179:79-84. doi: 10.1016/j.ygyno.2023.10.020. Epub 2023 Nov 8. Gynecol Oncol. 2023. PMID: 37944329 Review.

2

Adaptive Lumpectomy Boost Planning Can Reduce Normal Tissue Exposure in Patients Receiving Hypofractionated Whole Breast Irradiation.

Sayan M, Yehia ZA, Jan I, Gupta A, Vergalasova I, Reviello M, Kumar S, Haffty B, Ohri N. Sayan M, et al. Among authors: vergalasova i. Anticancer Res. 2022 Jan;42(1):53-57. doi: 10.21873/anticanres.15456. Anticancer Res. 2022. PMID: 34969708

3

Clinical Evaluation of the Inverse Planning System Utilized in Gamma Knife Lightning.

Cui T, Nie K, Zhu J, Danish S, Weiner J, Chundury A, Ohri N, Zhang Y, Vergalasova I, Yue N, Wang X. Cui T, et al. Among authors: vergalasova i. Front Oncol. 2022 Feb 23;12:832656. doi: 10.3389/fonc.2022.832656. eCollection 2022. Front Oncol. 2022. PMID: 35280733 Free PMC article.

4

The Impact of Everolimus and Radiation Therapy on Pulmonary Fibrosis.

Eren MF, Ay Eren A, Sayan M, Yücel B, Elagöz Ş, Özgüven Y, Vergalasova I, Altun A, Kılıçkap S, Daliparty V, Beşe N. Eren MF, et al. Among authors: vergalasova i. Medicina (Kaunas). 2020 Jul 13;56(7):348. doi: 10.3390/medicina56070348. Medicina (Kaunas). 2020. PMID: 32668776 Free PMC article.

5

Incidence of clinical lymphedema in breast cancer patients treated with adjuvant proton-based radiotherapy.

Sayan M, Jan I, Vergalasova I, Kilic SS, Kumar S, Haffty B, Ohri N. Sayan M, et al. Among authors: vergalasova i. Rep Pract Oncol Radiother. 2022 Jul 29;27(3):474-478. doi: 10.5603/RPOR.a2022.0053. eCollection 2022. Rep Pract Oncol Radiother. 2022. PMID: 36186685 Free PMC article.

6

Risk Factors for the Development of Clinical and Subclinical Lymphedema Detected by Bioimpedance Spectroscopy.

Sayan M, Kilic SS, Vergalasova I, Jan I, Eladoumikdachi F, Haffty B, Kumar S, Ohri N. Sayan M, et al. Among authors: vergalasova i. Clin Breast Cancer. 2022 Aug;22(6):553-559. doi: 10.1016/j.clbc.2022.04.003. Epub 2022 Apr 22. Clin Breast Cancer. 2022. PMID: 35589489

7

Does Prophylactic Paraortic Lymph Node Irradiation Improve Outcomes in Women With Stage IIIC1 Endometrial Carcinoma?

Yoon J, Fitzgerald H, Wang Y, Wang Q, Vergalasova I, Elshaikh MA, Dimitrova I, Damast S, Li JY, Fields EC, Beriwal S, Keller A, Kidd EA, Usoz M, Jolly S, Jaworski E, Leung EW, Donovan E, Taunk NK, Chino J, Natesan D, Russo AL, Lea JS, Albuquerque KV, Lee LJ, Hathout L. Yoon J, et al. Among authors: vergalasova i. Pract Radiat Oncol. 2022 Mar-Apr;12(2):e123-e134. doi: 10.1016/j.prro.2021.10.002. Epub 2021 Nov 23. Pract Radiat Oncol. 2022. PMID: 34822999

8

Performance assessment of two motion management systems for frameless stereotactic radiosurgery.

Wang H, Xu Z, Grantham K, Zhou Y, Cui T, Zhang Y, Liu B, Wang X, Vergalasova I, Reyhan M, Weiner J, Danish SF, Yue N, Nie K. Wang H, et al. Among authors: vergalasova i. Strahlenther Onkol. 2021 Feb;197(2):150-157. doi: 10.1007/s00066-020-01688-8. Epub 2020 Oct 12. Strahlenther Onkol. 2021. PMID: 33047151 Free PMC article.

9

Point/Counterpoint. Universal implementation of automated treatment planning software will be detrimental to future generations of trainees.

Vergalasova I, Li T, Cai J. Vergalasova I, et al. Med Phys. 2021 Jul;48(7):3409-3412. doi: 10.1002/mp.14900. Epub 2021 May 16. Med Phys. 2021. PMID: 33928653 No abstract available.

10

Toxicities and Locoregional Control After External Beam Chest Wall and/or Regional Lymph Node Re-irradiation for Recurrent Breast Cancer.

Sayan M, Vergalasova I, Jan I, Kumar S, Chan N, Haffty BG, Ohri N. Sayan M, et al. Among authors: vergalasova i. Anticancer Res. 2022 Jan;42(1):93-96. doi: 10.21873/anticanres.15461. Anticancer Res. 2022. PMID: 34969713

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

36 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year